Calbros Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
About Calbros Pharma India
Calbros Pharma India Private Limited (CPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 December 2019 (Five years and one month 2 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjita Kalra, Ankit Kalra, and Sakshi Kalra serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2019PTC359570
-
Company No.
359570
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Dec 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Calbros Pharma India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjita Kalra
|
Director | 28-Jan-2020 | Current |
|
Ankit Kalra
|
Whole-Time Director | 31-Dec-2019 | Current |
|
Sakshi Kalra
|
Director | 31-Dec-2019 | Current |
Financial Performance of Calbros Pharma India.
Calbros Pharma India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Calbros Pharma India?
In 2020, Calbros Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kalra Hospital Srcnc Private LimitedSanjita Kalra and Ankit Kalra are mutual person
-
Kalra Hospital Private Limited
Sanjita Kalra and Ankit Kalra are mutual person
-
Wellness Kart Private LimitedSanjita Kalra, Ankit Kalra and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Calbros Pharma India?
Unlock and access historical data on people associated with Calbros Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Calbros Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Calbros Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.